Exclusive news on life-science start-up fundings: Cameron, Nellix, Miramar, Chestnut
We’ve just posted a number of exclusive life-science fundings over at VentureBeat LifeScience. Click on the following links for news on:
- Cameron Health (San Clemente, Calif.), a maker of implantable defibrillators
- Nellix (Palo Alto, Calif.), a device-maker focused on aneurysms
- Miramar Labs (Menlo Park, Calif.), a developer of cosmetic-surgery devices
- Chestnut Medical Technologies (Menlo Park, Calif.), a maker of blood-clot removal devices
Next Story: Bungee Labs raises $8M for app development platform
Previous Story: Audio post: A gaming-centric idea roundup from SXSW
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
VentureBeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, GamesBeat
- Anthony Ha, Assistant Editor, VentureBeat
- Camille Ricketts, Lead Writer, GreenBeat
- Paul Boutin, Writer, VentureBeat
- Kim-Mai Cutler, Writer, VentureBeat
- Matthaus Krzykowski, Mobile Consultant & Coordinator
VentureBeat Start-Up Index
An index of the hottest startups, measured by trends in their traffic, news coverage, buzz and funding.